Literature DB >> 8370587

Polymorphisms of the apolipoprotein B and E genes and their relationship to plasma lipid variables in healthy Chinese men.

A E Evans1, W Zhang, J F Moreel, J M Bard, S Ricard, O Poirier, L Tiret, J C Fruchart, F Cambien.   

Abstract

In this study we have analysed the apolipoprotein (Apo) E polymorphism and polymorphisms of the ApoB gene, including the ApoB/XbaI and ApoB/4311 diallelic polymorphisms and a hypervariable region (HVR) situated in the 3' region of the gene (ApoB/3'HVR), in a sample of healthy male subjects from Taiyuan (northern People's Republic of China). In comparison to Caucasian populations, in the Chinese sample, the XbaI2 allele (presence of cutting site; frequency 6.1%; and 95% confidence interval, 3.3-8.9) and the long HVR alleles (9.4%; 6.0-12.8) were rare, whereas the ApoB/4311 (Ser) allele (70.8%; 65.4-76.2) and the 34-repeat allele of the HVR (HVR34; 62.4%; 56.8-68.0) were frequent. In subjects having none, one, or two HVR34 alleles, the mean levels of plasma triglycerides were 2.32 +/- 1.44 (SD), 1.45 +/- 0.74, and 1.75 +/- 1.07 g/l, respectively (P < 0.007). Similar trends were observed for very low density lipoprotein (VLDL) cholesterol, LpE:B, and LpCIII:B. The frequencies of the ApoE alleles were similar to those reported in other populations of Asian origin; E2 (7.4%; 4.2-10.6), E3 (84.4%; 80.2-88.6), and E4 (8.2%; 5.0-11.4). Individuals carrying the E2 allele had a lower mean level of ApoB than E33 individuals: 0.87 +/- 0.16 and 1.00 +/- 0.22 g/l, respectively (P < 0.007). Individuals carrying the E4 allele had higher levels of ApoE than E33 individuals: 0.140 +/- 0.084 and 0.094 +/- 0.052 g/l, respectively (P < 0.004); similar trends were observed for VLDL cholesterol, triglycerides, LpE:B, and LpCIII:B. The ApoB/HVR34 and ApoE/E4 polymorphisms accounted for 10% to 15% of the variability of the plasma levels of VLDL cholesterol, ApoE, triglycerides, LpE:B, and LpCIII:B. Several lipid variables appeared to be favourably affected by specific forms of ApoB and ApoE that are particularly frequent in this Chinese population.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370587     DOI: 10.1007/bf00219691

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  35 in total

1.  Apolipoprotein (apo) E genotypes by polymerase chain reaction and allele-specific oligonucleotide probes: no detectable linkage disequilibrium between apo E and apo CII.

Authors:  R S Houlston; C Snowden; F Green; K G Alberti; S E Humphries
Journal:  Hum Genet       Date:  1989-11       Impact factor: 4.132

2.  Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism.

Authors:  E Boerwinkle; G Utermann
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

3.  Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels.

Authors:  M Smit; P de Knijff; M Rosseneu; J Bury; E Klasen; R Frants; L Havekes
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

4.  Genetic variation in serum low density lipoproteins and lipid levels in man.

Authors:  K Berg; C Hames; G Dahlén; M H Frick; I Krishan
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

5.  Apolipoprotein B-gene DNA polymorphisms (XbaI and EcoRI), serum lipids, and apolipoproteins in healthy Chinese.

Authors:  N Saha; J S Tay; S E Humphries
Journal:  Genet Epidemiol       Date:  1992       Impact factor: 2.135

6.  Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world.

Authors:  L U Gerdes; I C Klausen; I Sihm; O Faergeman
Journal:  Genet Epidemiol       Date:  1992       Impact factor: 2.135

7.  Two amino acid substitutions in apolipoprotein B are in complete allelic association with the antigen group (x/y) polymorphism: evidence for little recombination in the 3' end of the human gene.

Authors:  A M Dunning; H H Renges; C F Xu; R Peacock; R Brasseur; G Laxer; M J Tikkanen; R Bütler; N Saha; A Hamsten
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

Review 8.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

9.  Frequency and role of apo E phenotype in familial hypercholesterolemia and non-familial hyperlipidemia in the Japanese.

Authors:  M Kitahara; M Shinomiya; K Shirai; Y Saito; S Yoshida
Journal:  Atherosclerosis       Date:  1990-06       Impact factor: 5.162

10.  Serum high density lipoprotein cholesterol, apolipoprotein A-I, A-II and B levels in Singapore ethnic groups.

Authors:  N Saha
Journal:  Atherosclerosis       Date:  1987-11       Impact factor: 5.162

View more
  12 in total

1.  Interactions between life stress factors and carrying the APOE4 allele adversely impact self-reported health in old adults.

Authors:  Yi Zeng; Claude L Hughes; Megan A Lewis; Jianxin Li; Fengyu Zhang
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-07-18       Impact factor: 6.053

2.  Genetic Variation of ApoE Gene in Ethnic Kashmiri Population and Its Association with Outcome After Traumatic Brain Injury.

Authors:  Adfar Yousuf; Nayil Khursheed; Ishrat Rasool; Vijay Kundal; Humira Jeelani; Dil Afroze
Journal:  J Mol Neurosci       Date:  2015-04-10       Impact factor: 3.444

3.  APOE, MTHFR, LDLR and ACE polymorphisms among Angami and Lotha Naga populations of Nagaland, India.

Authors:  Benrithung Murry; Neikethono Vakha; Nongthombam Achoubi; M P Sachdeva; K N Saraswathy
Journal:  J Community Health       Date:  2011-12

4.  No change of the lipid profile under the control of ApoE gene polymorphism in schizophrenics under paliperidone treatment.

Authors:  Wei-Tsung Kao; Chen-Lin Chang; Yi-Lung Chen; For-Wey Lung
Journal:  Psychiatr Q       Date:  2014-12

5.  Higher alleles of apolipoprotein B gene 3' VNTR: Risk for gallstone disease.

Authors:  Manjusha Dixit; Anvesha Srivastava; Gourdas Choudhuri; Balraj Mittal
Journal:  Indian J Clin Biochem       Date:  2008-06-11

6.  Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals.

Authors:  Madhav Thambisetty; Romina Tripaldi; Joanna Riddoch-Contreras; Abdul Hye; Yang An; James Campbell; Jitka Sojkova; Anna Kinsey; Steven Lynham; Yun Zhou; Luigi Ferrucci; Dean F Wong; Simon Lovestone; Susan M Resnick
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  Plasma based markers of [11C] PiB-PET brain amyloid burden.

Authors:  Steven John Kiddle; Madhav Thambisetty; Andrew Simmons; Joanna Riddoch-Contreras; Abdul Hye; Eric Westman; Ian Pike; Malcolm Ward; Caroline Johnston; Michelle Katharine Lupton; Katie Lunnon; Hilkka Soininen; Iwona Kloszewska; Magda Tsolaki; Bruno Vellas; Patrizia Mecocci; Simon Lovestone; Stephen Newhouse; Richard Dobson
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

8.  Association between the APOB XbaI and EcoRI polymorphisms and lipids in Chinese: a meta-analysis.

Authors:  Wei Gu; Mingduo Zhang; Shaojun Wen
Journal:  Lipids Health Dis       Date:  2015-10-07       Impact factor: 3.876

Review 9.  Role of apolipoprotein E in neurodegenerative diseases.

Authors:  Vo Van Giau; Eva Bagyinszky; Seong Soo A An; Sang Yun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-16       Impact factor: 2.570

10.  Apolipoprotein Gene Polymorphisms (APOB, APOC111, APOE) in the Development of Coronary Heart Disease in Ethnic Groups of Kazakhstan.

Authors:  S Berkinbayev; M Rysuly; A Mussayev; K Blum; N Baitasova; A Mussagaliyeva; G Dzhunusbekova; B Makhatov; Aa Mussayev; A Yeshmanova; R Lesbekova; Y Marchuk; R Azhibekova; M Oscar-Berman; M Kulmaganbetov
Journal:  J Genet Syndr Gene Ther       Date:  2014-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.